Australian (ASX) Stock Market Forum

FER - Fermiscan Limited

Jump to new
S

scsl

Joined
11 June 2006
Posts
427
Reactions
0
I had the opportunity to sit in on a Fermiscan corporate presentation the other day, with the MD and Clinical Operations Manager present.

This company was established in 2004 to explore the possibilities in cancer diagnosis. Its patented Fermiscan Test uses x-ray diffraction analysis of hair to diagnose breast cancer. Definately unique huh!

It was put on the ASX via a back-door listing through Olympus and in less than two months, has shot up from about 30 cents to today's close of $1.12. This has been on the back of some very positive announcements.

One to watch... Worth doing some research on. I don't hold.
 
Had a very strong run yesterday.

Managed Fund has taken a stake in it.

Can go higher again today as there a very little sellers.
 
crazyjimsmith said:
Had a very strong run yesterday.

Managed Fund has taken a stake in it.

Can go higher again today as there a very little sellers.
Click to expand...
Which fund CrazyJim? Interesting.

Is that Manifest Capital Management??
 
Yeap Manifest.

I did a search and found out that they also hold a stake in Progen.

Had some weakness this morning but back up to $1.40 now which is a resistance level.

Guys this is a very dangerous trade if you are thinking about short term as there is little buyer support.

No sellers so buyers are chasing it higher.
 
This is definately being chased up. Any idea why the big jump CrazyJim? Trading at $1.65 now up 14% early. Had a significant run the past few days. Gone too hard?
 

Attachments

  • FER.gif
    FER.gif
    19.3 KB · Views: 331
No sellers and I guess the managed fund still wants the shares even at this level........

Ann on trials is also due but I don't know when.
 
I don't see why they should stop at breast cancer. If the technique works effectively (and I have no reason to doubt it) then why not any type of cancer? Imagine what would happen to the share price if, for example, they announced they were now perfecting a screen for colon cancer?

And if they aren't at least planning such, why not?
 
moses said:
I don't see why they should stop at breast cancer. If the technique works effectively (and I have no reason to doubt it) then why not any type of cancer? Imagine what would happen to the share price if, for example, they announced they were now perfecting a screen for colon cancer?

And if they aren't at least planning such, why not?
Click to expand...

I asked, here is the reply...

thanks for your enquiry. Whilst we are currently fully focussed on developing the breast cancer test for commercialisation, there are two scientific publications that indicate that the technology may be able to be used for detection of the presence of colon cancer and of Alzheimers disease, and we plan to develop these in the future. Other diseases may also be possible over time. Best wishes,
Dr Peter French
Science and Innovation Manager
 
Now $1.95, up 134% in 1 1/2 months.

Recently raised $22.5 million in a share placement, at an issue price of $1.50. Proceeds of which will be used to fund:

- Anticipated capital expenditure relating to access to dedicated Synchrotron beam lines including the x-ray diffraction equipment necessary to perform the Fermiscan test.
- Developing international and domestic markets for the Fermiscan technology. The company plans to market the Fermiscan test globally, and is currently examining selected markets in South East Asia and Japan.
- Working capital.

Very encouraging news.
 
I had a punt on a quick turn at $1.10 and took a small hit on it as the momentum on the first surge dried up.

If the trial goes well they could be worth a lot more, if not suggest you look at MBP for an idea of the possible outcome.

Also if you look at the options they granted the new non-exec directors (3.3m each at 30c) just before the shareprice rocketed you have to think it's a pretty spivvy management team.

Quoting their notice of meeting from 13/12 - "Whilst the issue of options to non-exec directors does not fully embodythe spirit of ASX governance council recommendation 9.3"....

The board has given the non execs an options package worth $6m each. Not bad for a couple of months in the job...
 
looks done. even trial result positive - there is competition for this product. be wary! and its not a drug either
 
FER is still on the rise. 17% today

Going back through the announcements to do some research. In that time its climbed from $2.37 to $2.52. Looks interesting so far.
 
22/2/07 Close at 2.50
23/2/07 Open at 2.70

10:20am hit a high of 2.85

Technology looks sound, clinics seem eager and positive on the trials.
 
Took a punt, bought some on Wed at $2.00....Now $2.64.

Very happy at the moment...Still think it will rise further next week.

Royce
 
This might go ok today on this news, unless it's factored in:

The Age said:
Fermiscan licences breast cancer test
March 20, 2007 - 11:24PM

The Australian developer of a test for breast cancer that uses a piece of a patient's hair has signed a licensing agreement giving it access to five South-East Asian countries and Hong Kong.

Fermiscan Holdings Ltd's breast cancer test is undergoing a validation trial in Australia, with the company expecting to have the test available by the end of the year.
Click to expand...
 
The announcement yesterday was a good one. My interpretation was that they must be receiving positive results in the trials if they are trying to expand into the SE Asian market
 
i dont hold this stock, but i am watching it closely.
Hoping for some weakness soon in the SP and then pick some up. The SP could be anywhere in 6 months both high and low, not easy to call.
 
What's going on with this stock? The price has been hammered - now even with the sub prime jitters this is getting ridiculous. Down from 2.20 to 1 in a few weeks. $1 today! This hasn't had any form of recovery at all. It just keeps dropping.

Are their trials going badly and people jumping ship? I thought their product was basically a sure thing.... the preliminary trial results have been excellent.

Anyone have any ideas?

Perhaps just major stop-loss triggers that keep pushing it down.
 
Top